ITU Unit Action

NEXCELUS

Bellicum Pharmaceuticals, Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action)
OVERVIEW
SERIAL NUMBER	87168201	FILING DATE	09/12/2016
REG NUMBER	0000000	REG DATE	N/A
REGISTER	PRINCIPAL	MARK TYPE	TRADEMARK
INTL REG #	N/A	INTL REG DATE	N/A
TM ATTORNEY	SONNEBORN, TRICIA L	L.O. ASSIGNED	110

PUB INFORMATION
RUN DATE	03/18/2020
PUB DATE	08/01/2017
STATUS	734-FIFTH EXTENSION - GRANTED
STATUS DATE	03/17/2020
LITERAL MARK ELEMENT	NEXCELUS

DATE ABANDONED	N/A	DATE CANCELLED	N/A
SECTION 2F	NO	SECTION 2F IN PART	NO
SECTION 8	NO	SECTION 8 IN PART	NO
SECTION 15	NO	REPUB 12C	N/A
RENEWAL FILED	NO	RENEWAL DATE	N/A
DATE AMEND REG	N/A

FILING BASIS
FILED BASIS		CURRENT BASIS		AMENDED BASIS
1 (a)	NO	1 (a)	NO	1 (a)	NO
1 (b)	YES	1 (b)	YES	1 (b)	NO
44D	NO	44D	NO	44D	NO
44E	NO	44E	NO	44E	NO
66A	NO	66A	NO
NO BASIS	NO	NO BASIS	NO

MARK DATA
STANDARD CHARACTER MARK	YES
LITERAL MARK ELEMENT	NEXCELUS
MARK DRAWING CODE	4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG	NO

CURRENT OWNER INFORMATION
PARTY TYPE	20-OWNER AT PUBLICATION
NAME	Bellicum Pharmaceuticals, Inc.
ADDRESS	2130 W. Holcombe Drive, Suite 800 Houston, TX 77030
ENTITY	03-CORPORATION
CITIZENSHIP	Delaware

GOODS AND SERVICES
INTERNATIONAL CLASS	005
DESCRIPTION TEXT	Pharmaceutical preparations for use in connection with cellular transplants

GOODS AND SERVICES CLASSIFICATION
INTERNATIONAL CLASS	005	FIRST USE DATE	NONE	FIRST USE IN COMMERCE DATE	NONE	CLASS STATUS	6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS
CHANGE IN REGISTRATION	NO

PROSECUTION HISTORY
DATE	ENT CD	ENT TYPE	DESCRIPTION	ENT NUM
03/18/2020	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	035
03/17/2020	EX5G	S	EXTENSION 5 GRANTED	034
03/09/2020	EXT5	S	EXTENSION 5 FILED	033
03/17/2020	AITU	A	CASE ASSIGNED TO INTENT TO USE PARALEGAL	032
03/09/2020	EEXT	I	TEAS EXTENSION RECEIVED	031
09/21/2019	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	030
09/19/2019	EX4G	S	EXTENSION 4 GRANTED	029
09/19/2019	EXT4	S	EXTENSION 4 FILED	028
09/19/2019	EEXT	I	TEAS EXTENSION RECEIVED	027
03/21/2019	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	026
03/19/2019	EX3G	S	EXTENSION 3 GRANTED	025
03/19/2019	EXT3	S	EXTENSION 3 FILED	024
03/19/2019	EEXT	I	TEAS EXTENSION RECEIVED	023
09/26/2018	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	022
09/24/2018	EX2G	S	EXTENSION 2 GRANTED	021
09/24/2018	EXT2	S	EXTENSION 2 FILED	020
09/24/2018	EEXT	I	TEAS EXTENSION RECEIVED	019
03/22/2018	EXRA	E	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	018
03/20/2018	EX1G	S	EXTENSION 1 GRANTED	017
03/20/2018	EXT1	S	EXTENSION 1 FILED	016
03/20/2018	EEXT	I	TEAS EXTENSION RECEIVED	015
09/26/2017	NOAM	E	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	014
08/01/2017	NPUB	E	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	013
08/01/2017	PUBO	A	PUBLISHED FOR OPPOSITION	012
07/12/2017	NONP	E	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	011
06/21/2017	CNSA	P	APPROVED FOR PUB - PRINCIPAL REGISTER	010
06/03/2017	TEME	I	TEAS/EMAIL CORRESPONDENCE ENTERED	009
06/01/2017	CRFA	I	CORRESPONDENCE RECEIVED IN LAW OFFICE	008
06/01/2017	TROA	I	TEAS RESPONSE TO OFFICE ACTION RECEIVED	007
12/12/2016	GNRN	O	NOTIFICATION OF NON-FINAL ACTION E-MAILED	006
12/12/2016	GNRT	F	NON-FINAL ACTION E-MAILED	005
12/12/2016	CNRT	R	NON-FINAL ACTION WRITTEN	004
12/08/2016	DOCK	D	ASSIGNED TO EXAMINER	003
09/15/2016	NWOS	I	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	002
09/15/2016	NWAP	I	NEW APPLICATION ENTERED IN TRAM	001

CURRENT CORRESPONDENCE INFORMATION
ATTORNEY	John Paul Oleksiuk
CORRESPONDENCE ADDRESS	John Paul Oleksiuk COOLEY LLP 1299 PENNSYLVANIA AVENUE, NW, SUITE 700 WASHINGTON DC 20004-2400
DOMESTIC REPRESENTATIVE	NONE

PRIOR OWNER INFORMATION
PARTY TYPE	10-ORIGINAL APPLICANT
NAME	Bellicum Pharmaceuticals, Inc.
ADDRESS	2130 W. Holcombe Drive, Suite 800 Houston, TX 77030
ENTITY	03-CORPORATION
CITIZENSHIP	Delaware

ITU Unit Action [image/jpeg]

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.